Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Stevens

Showing results (471-480 of 486) with videos related to

Pageof 49
Sort By:
Structure (London, England : 1993)|February 6, 2026
Structural basis for pan-coronavirus inhibition of 3CL proteaseEswar R Reddem, Farhad Forouhar, Cheng Liu, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 17, 2014
Influenza at the animal-human interface: a review of the literature for virological evidence of human infection with swine or avian influenza viruses other than A(H5N1)G S Freidl, A Meijer, E de Bruin, et al.
Journal of Medicinal Chemistry|September 2, 2024
Discovery and Preclinical Profile of ALG-055009, a Potent and Selective Thyroid Hormone Receptor Beta (THR-β) Agonist for the Treatment of MASHKoen Vandyck, David C McGowan, Xuan G Luong, et al.
Mbio|January 10, 2023
The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor <i>In Vitro</i> and Confer Resistance To NirmatrelvirDirk Jochmans, Cheng Liu, Kim Donckers, et al.
European Journal of Clinical Nutrition|May 23, 2013
Intake and dietary sources of haem and non-haem iron among European adolescents and their association with iron status and different lifestyle and socio-economic factorsS Vandevijvere, N Michels, S Verstraete, et al.
Antimicrobial Agents and Chemotherapy|October 1, 2008
Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227)Scott D Seiwert, Steven W Andrews, Yutong Jiang, et al.
Genome Research|May 10, 2013
NAHR-mediated copy-number variants in a clinical population: mechanistic insights into both genomic disorders and Mendelizing traitsPiotr Dittwald, Tomasz Gambin, Przemyslaw Szafranski, et al.
Endoscopy|September 4, 2020
Endoscopic ultrasound-directed transgastric ERCP (EDGE): a retrospective multicenter studyThomas M Runge, Austin L Chiang, Thomas E Kowalski, et al.
Nature|October 5, 2001
Genome sequence of Yersinia pestis, the causative agent of plagueJ Parkhill, B W Wren, N R Thomson, et al.
Neoplasia (New York, N.Y.)|January 16, 2026
Dual CDK4/6-PI3K/mTOR inhibition reinforces cytostatic programs and tumor control in preclinical models of primary and metastatic osteosarcomaFarinaz Barghi, M Reza Saadatzadeh, Erika A Dobrota, et al.
Pageof 49

Showing results (471-480 of 486) with videos related to

Sort By:
Pageof 49
Structure (London, England : 1993)|February 6, 2026
Structural basis for pan-coronavirus inhibition of 3CL proteaseEswar R Reddem, Farhad Forouhar, Cheng Liu, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 17, 2014
Influenza at the animal-human interface: a review of the literature for virological evidence of human infection with swine or avian influenza viruses other than A(H5N1)G S Freidl, A Meijer, E de Bruin, et al.
Journal of Medicinal Chemistry|September 2, 2024
Discovery and Preclinical Profile of ALG-055009, a Potent and Selective Thyroid Hormone Receptor Beta (THR-β) Agonist for the Treatment of MASHKoen Vandyck, David C McGowan, Xuan G Luong, et al.
Mbio|January 10, 2023
The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor <i>In Vitro</i> and Confer Resistance To NirmatrelvirDirk Jochmans, Cheng Liu, Kim Donckers, et al.
European Journal of Clinical Nutrition|May 23, 2013
Intake and dietary sources of haem and non-haem iron among European adolescents and their association with iron status and different lifestyle and socio-economic factorsS Vandevijvere, N Michels, S Verstraete, et al.
Antimicrobial Agents and Chemotherapy|October 1, 2008
Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227)Scott D Seiwert, Steven W Andrews, Yutong Jiang, et al.
Genome Research|May 10, 2013
NAHR-mediated copy-number variants in a clinical population: mechanistic insights into both genomic disorders and Mendelizing traitsPiotr Dittwald, Tomasz Gambin, Przemyslaw Szafranski, et al.
Endoscopy|September 4, 2020
Endoscopic ultrasound-directed transgastric ERCP (EDGE): a retrospective multicenter studyThomas M Runge, Austin L Chiang, Thomas E Kowalski, et al.
Nature|October 5, 2001
Genome sequence of Yersinia pestis, the causative agent of plagueJ Parkhill, B W Wren, N R Thomson, et al.
Neoplasia (New York, N.Y.)|January 16, 2026
Dual CDK4/6-PI3K/mTOR inhibition reinforces cytostatic programs and tumor control in preclinical models of primary and metastatic osteosarcomaFarinaz Barghi, M Reza Saadatzadeh, Erika A Dobrota, et al.
Pageof 49